Wolgen paints things a bit different then I would (process in Europe) The main update I noticed on first read are commercially available in austria and netherlands and still available under the access schemes in Italy and Switzerland (but no mention if its the commercial price so I'd guess its not)
I don't know if its deliberate or incompetence but they mention the EPP Workshop/conference FDA is holding October 24th as invitees only when it certainly appears to be open for the public http://www.fda.gov/Drugs/NewsEvents/ucm501389.htm
If you follow the link on the page you can register and then get an email with a link to the webcast of the event when its available.
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM